Paracetamol is one of the most common off the shelf drugs that is sold all over the world. It is the basic remedy for fever and body aches. However, latest study has shown that too much of intake of paracetamol can lead to gradual accumulation over time, which can lead to a fatal overdose in Read more
Nitroglycerin is the most popular and effective drug that is administered to heart patients. However, latest studies have shown that when used continuously for prolonged duration, this drug can cause severe damage to the heart. The chance of subsequent heart attacks increases drastically. The study was carried out on laboratory mice by Stanford University School Read more
Valeant Pharmaceutical is still ongoing with its shopping spree as they continue with their goal of becoming one of the largest dermatological treatment companies worldwide. On Friday, the company announces their intentions to buy the Ortho Dermatologics division of Janssen Pharmaceuticals Inc. for $345 million. The same company has a sale of $150 million last Read more
Researchers have found new drugs that may benefit in treating men who are diagnosed with advanced prostate cancer. However, the new drugs are estimated to add several billions to the country’s medical bill. In the last fifteen months, the Foods and Drugs Administration have approved three new medications and there are several other drugs that Read more
Patients suffering from breast cancer have been making a case for the Foods and Drugs Administration to approve Avastin as a prescribed medication for treating the illness. These presentations were made on the first day of the two-day hearing under progress. Genetech, which manufactures Avastin, is working to convince the FDA to reverse its December Read more
A medication for treatment of hereditary angioedema in patients whose age is above is 18 years namely Firazyr (22150, icatibant solution) became a subject for voting in FDA Pulmonary-Allergy Drugs Advisory Committee. The votes were 11 of 12 in favour of Firazyr. The committee’s recommendations are although void; however FDA favours Committee’s advice. But the Read more
Canakinumab(ACZ885), human monoclonal antibody finds rejection as the advisors of the US Food and Drug Administration donot approve it for the treatment of gout.The Novartis drug Canakinumab got approval for the treatment of (CAPS-Cryopyrin periodic syndromes) by US FDA(June 2009) and by EMA(October 2009).Canakinumab(Ilaris) is a recombinant Interleukin-1 beta inhibitor.
The two US based pharmaceutical companies Bristol-Myers Squibb and Pfizer are thrilled with the news that their experimental anti-coagulant drug Eliquis has passed a late stage trial (third phase) successfully. Both the firms have ecstatically announced success at the third phase of the trial (ARISTOTLE) of the drug. The trial was conducted for patients suffering Read more
Researchers say that in Scotland, almost 60,000 patients are being given drugs which pose a high risk of side effects. Scientists at the University of Dundee, found that admissions into hospitals and even deaths are intricately related to the preventable side effects of the drugs that are being given to the patients in primary care. Read more
New FDA policy to monitor imports The commissioner of the Foods and Drugs Administration, Dr. Margaret Hamburg has spoken about the overwhelming amount of imports of foods and drugs within the country. She has now proposed a new policy to enabler the FDA to regulate the inflow of imported foods and drugs. The new framework Read more
In the final draft guidance by cost regulators, patients in England and Wales who have suffered a specific kind of heart attack (STEMI) have been provided access to the drug Angiox by The Medicines Company on the National Health Service.
The news is making waves all over the world that at the young age of twenty-four, The Florida businessman Ethan Lewis by now has set his eyes on creating the socially responsible business. The Tampa businessman in recent times started a product called GlucoBrand’s LLC, to create and market innovative lifestyle solutions for the people Read more